Back to search
Creutzfeldt Jakob Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Creutzfeldt Jakob Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Creutzfeldt Jakob Disease trials you may qualify forThe purpose of this trial is to evaluate safety, tolerability, pharmacokinetics and pharmacodynamic impact of PrP-siRNA in symptomatic prion disease patients.
We are doing this research to identify biomarkers in individuals who are at-risk for familial prion disease. We hope to use these biomarkers to predict timing o…
The goal of this clinical trial is to improve communication among clinicians, patients with memory problems, and their family members. We are testing a way to h…
FLOWER is a completely virtual, nationwide, real-world observational study to collect, annotate, standardize, and report clinical data for rare diseases. Patien…
Creutzfeldt-Jakob Disease (CJD) is the most common prion disease in humans causing a rapidly progressive neurological decline and dementia and is invariably fat…
The primary objective of this observational study is to investigate alterations in PrPc levels in peripheral blood during acute cerebral infarction, as well as…
This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial designed to evaluate the efficacy and safety of efavirenz in…
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S and cAd3 Marburg vaccines when administered Intramuscular (IM) at a dose of 1 x 10\^…